Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

CD28 fusions: an opportunity for young ATL?

Lucy B. M. Cook, Aileen G. Rowan

Blood (2020) 135 (17): 1415–1416.

https://doi.org/10.1182/blood.2020004958

Published: 2020

Journal Articles

Validation of Clinical Prognostic Models and Integration of Genetic Biomarkers of Drug Resistance in CLL Patients Treated with Ibrutinib

Inhye E. Ahn, MD, Xin Tian, Maher Albitar, MD, Sarah E. M. Herman, PhD, Erika M. Cook, Susan Soto, Wanlong Ma, David Ipe, L. Claire Tsao, Mei Cheng, James P. Dean, Adrian Wiestner, MD

Blood (2018) 132 (Supplement 1): 186.

https://doi.org/10.1182/blood-2018-99-110326

Published: 2018

Journal Articles

Duohexabody-CD37, a Novel Bispecific Antibody with a Hexamerization-Enhancing Mutation Targeting CD37, Demonstrates Superior Complement-Dependent Cytotoxicity in Preclinical B-Cell Malignancy Models

Simone C. Oostindie, MSc, Hilma J. Van Der Horst, MSc, Marije B. Overdijk, PhD, Kristin Strumane, PhD, Sandra Verploegen, PhD, Margaret A. Lindorfer, PhD, Erica M. Cook, B.A., Martine E.D. Chamuleau, MD, Tuna Mutis, PhD, Janine Schuurman, PhD, A. Kate Sasser, PhD, Ronald P. Taylor, PhD, Paul W. H. I. Parren, PhD, Frank J. Beurskens, PhD, Esther C. W. Breij, PhD

Blood (2018) 132 (Supplement 1): 4170.

https://doi.org/10.1182/blood-2018-99-114723

Published: 2018

Journal Articles

Variable Bruton Tyrosine Kinase (BTK) Resynthesis across Patients with Chronic Lymphocytic Leukemia (CLL) on Acalabrutinib Therapy Affect Target Occupancy and Reactivation of B-Cell Receptor (BCR) Signaling

Anfal A. Alsadhan, Jean Cheung, Michael Gulrajani, Erika M. Cook, Stefania Pittaluga, MD PhD, Theresa Davies-Hill, Raquel Izumi, PhD, Clare C. Sun, MD, Todd Covey, PhD, Adrian Wiestner, MD, Sarah E. M. Herman, PhD

Blood (2018) 132 (Supplement 1): 4401.

https://doi.org/10.1182/blood-2018-99-110391

Published: 2018

Journal Articles

Ibrutinib Increases the Clonality of TCR Repertoire in Patients with Chronic Lymphocytic Leukemia

Maria Joao Baptista, PhD PharmD, Neil Basumallik, Sarah E. M. Herman, PhD, Erika M. Cook, Inhye E. Ahn, MD, Adrian Wiestner, MD, Clare C. Sun, MD

Blood (2018) 132 (Supplement 1): 238.

https://doi.org/10.1182/blood-2018-99-109847

Published: 2018

Journal Articles

A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era

Hannah R. Robinson, Junpeng Qi, Erika M. Cook, Cydney Nichols, Eman L. Dadashian, Chingiz Underbayev, Sarah E. M. Herman, Nakhle S. Saba, Keyvan Keyvanfar, Clare Sun, Inhye E. Ahn, Sivasubramanian Baskar, Christoph Rader, Adrian Wiestner

Blood (2018) 132 (5): 521–532.

https://doi.org/10.1182/blood-2018-02-830992

Published: 2018

Includes: Supplemental data

Journal Articles

Recovery Blasts in the Peripheral Blood in AML Patients Who Obtain a Complete Remission Is a Favorable Prognostic Indicator

Nathaniel M. Cook, MD, James N. Butera, MD, John L Reagan, MD

Blood (2014) 124 (21): 5335.

https://doi.org/10.1182/blood.V124.21.5335.5335

Published: 2014

Journal Articles

Race-Specific Features and Treatment Patterns of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) in the United States: Analysis of the National Cancer Data Base

Rajesh Shrestha, MD, Nathaniel M. Cook, MD, Adam J. Olszewski, MD

Blood (2014) 124 (21): 2594.

https://doi.org/10.1182/blood.V124.21.2594.2594

Published: 2014

Journal Articles

Inhibiting stromal cell heparan sulfate synthesis improves stem cell mobilization and enables engraftment without cytotoxic conditioning

Blood (2014) 124 (19): 2937–2947.

https://doi.org/10.1182/blood-2014-08-593426

Published: 2014

Includes: Supplemental data

Journal Articles

Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells

Amy M. Cook, Liang Li, Yinwei Ho, Allen Lin, Ling Li, Anthony Stein, Stephen Forman, Danilo Perrotti, Richard Jove, Ravi Bhatia

Blood (2014) 123 (18): 2826–2837.

https://doi.org/10.1182/blood-2013-05-505735

Published: 2014

Includes: Supplemental data

Journal Articles

Control of blood proteins by functional disulfide bonds

Diego Butera, Kristina M. Cook, Joyce Chiu, Jason W. H. Wong, Philip J. Hogg

Blood (2014) 123 (13): 2000–2007.

https://doi.org/10.1182/blood-2014-01-549816

Published: 2014

Journal Articles

Aldehyde Dehydrogenase 3a2 (Aldh3a2) Represents a Distinct Metabolic Vulnerability in MLL-AF9 AML Leukemia Initiating Cells

Blood (2012) 120 (21): 208.

https://doi.org/10.1182/blood.V120.21.208.208

Published: 2012

Journal Articles

Hematopoietic Stem/Progenitor Cell Retention in the Bone Marrow Depends On Tissue Specific Heparan Sulfate Proteoglycans

Borja Saez, PhD, Francesca Ferraro, MD, Rushdia Z. Yusuf, MBBS, MPH, Colleen M Cook, BA, Stephen M. Sykes, PhD, Ana Pardo, PhD, Vionnie W.C. Yu, PhD, Sutada Lotinun, Rahul Palchaudhuri, PhD, Dongjun Lee, PhD, Stefania Lymperi, BSc, MSc, PhD, Robyn Day, Radovan Vasic, Sanket S. Acharya, BA, MBS, Roland Baron, Amy J. Wagers, PhD, David T. Scadden, MD

Blood (2012) 120 (21): 637.

https://doi.org/10.1182/blood.V120.21.637.637

Published: 2012

Journal Articles

Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation

Andrea U. Steinbicker, Chetana Sachidanandan, Ashley J. Vonner, Rushdia Z. Yusuf, Donna Y. Deng, Carol S. Lai, Kristen M. Rauwerdink, Julia C. Winn, Borja Saez, Colleen M. Cook, Brian A. Szekely, Cindy N. Roy, Jasbir S. Seehra, Gregory D. Cuny, David T. Scadden, Randall T. Peterson, Kenneth D. Bloch, Paul B. Yu

Blood (2011) 117 (18): 4915–4923.

https://doi.org/10.1182/blood-2010-10-313064

Published: 2011

Includes: Supplemental data

Journal Articles

The Effect of Rituximab on Mobilization with AMD3100 Plus G-CSF in Patients with Relapsed or Refractory NHL or HD.

Jonathan L. Kaufman, MD, Amanda M. Cook, CCRP, Christopher Flowers, MD, Amelia A. Langston, MD, Sagar Lonial, MD, Mary Jo Lechowicz, MD, H. Jean Khoury, MD, Gary Calandra, MD, Ned Waller, MD, PhD

Blood (2007) 110 (11): 1912.

https://doi.org/10.1182/blood.V110.11.1912.1912

Published: 2007

Journal Articles

ABCG2 expression, function, and promoter methylation in human multiple myeloma

Joel G. Turner, Jana L. Gump, Chunchun Zhang, James M. Cook, Douglas Marchion, Lori Hazlehurst, Pamela Munster, Michael J. Schell, William S. Dalton, Daniel M. Sullivan

Blood (2006) 108 (12): 3881–3889.

https://doi.org/10.1182/blood-2005-10-009084

Published: 2006

Journal Articles

Allogeneic Stem Cell Transplantation Using a Reduced Intensity Conditioning (RIC) Regimen Has the Capacity To Produce Durable Remissions and Long Term Disease-Free Survival in Patients with High Risk Acute Myeloid Leukemia (AML).

Blood (2005) 106 (11): 1141.

https://doi.org/10.1182/blood.V106.11.1141.1141

Published: 2005

Journal Articles

Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species

Tracy L. Deem, Joan M. Cook-Mills

Blood (2004) 104 (8): 2385–2393.

https://doi.org/10.1182/blood-2004-02-0665

Published: 2004

Journal Articles

Leukemia translocation gene, PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors

A Reid, A Gould, N Brand, M Cook, P Strutt, J Li, J Licht, S Waxman, R Krumlauf, A Zelent

Blood (1995) 86 (12): 4544–4552.

https://doi.org/10.1182/blood.V86.12.4544.bloodjournal86124544

Published: 1995

NARROW

CD28 fusions: an opportunity for young ATL?

Validation of Clinical Prognostic Models and Integration of Genetic Biomarkers of Drug Resistance in CLL Patients Treated with Ibrutinib

Duohexabody-CD37, a Novel Bispecific Antibody with a Hexamerization-Enhancing Mutation Targeting CD37, Demonstrates Superior Complement-Dependent Cytotoxicity in Preclinical B-Cell Malignancy Models

Variable Bruton Tyrosine Kinase (BTK) Resynthesis across Patients with Chronic Lymphocytic Leukemia (CLL) on Acalabrutinib Therapy Affect Target Occupancy and Reactivation of B-Cell Receptor (BCR) Signaling

Ibrutinib Increases the Clonality of TCR Repertoire in Patients with Chronic Lymphocytic Leukemia

A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era

Recovery Blasts in the Peripheral Blood in AML Patients Who Obtain a Complete Remission Is a Favorable Prognostic Indicator

Race-Specific Features and Treatment Patterns of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) in the United States: Analysis of the National Cancer Data Base

Inhibiting stromal cell heparan sulfate synthesis improves stem cell mobilization and enables engraftment without cytotoxic conditioning

Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells

Control of blood proteins by functional disulfide bonds

Aldehyde Dehydrogenase 3a2 (Aldh3a2) Represents a Distinct Metabolic Vulnerability in MLL-AF9 AML Leukemia Initiating Cells

Hematopoietic Stem/Progenitor Cell Retention in the Bone Marrow Depends On Tissue Specific Heparan Sulfate Proteoglycans

Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation

The Effect of Rituximab on Mobilization with AMD3100 Plus G-CSF in Patients with Relapsed or Refractory NHL or HD.

ABCG2 expression, function, and promoter methylation in human multiple myeloma

Allogeneic Stem Cell Transplantation Using a Reduced Intensity Conditioning (RIC) Regimen Has the Capacity To Produce Durable Remissions and Long Term Disease-Free Survival in Patients with High Risk Acute Myeloid Leukemia (AML).

Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species

Leukemia translocation gene, PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only